REGN
38
-2
HST
39
-3
LEN
50
-2
STI
45
26
FFIV
66
-4
C
62
4
SCHW
62
-2
MCD
52
-5
CFG
74
2
MDLZ
32
-4
AMAT
33
-13
SYF
86
-6
VRSN
53
-5
OMC
50
-16
JBHT
56
-3
ETN
75
-3
FMC
23
-3
ZTS
47
2
AAPL
40
-6
RSG
65
-3
REGN
38
-2
HST
39
-3
LEN
50
-2
STI
45
26
FFIV
66
-4
C
62
4
SCHW
62
-2
MCD
52
-5
CFG
74
2
MDLZ
32
-4
AMAT
33
-13
SYF
86
-6
VRSN
53
-5
OMC
50
-16
JBHT
56
-3
ETN
75
-3
FMC
23
-3
ZTS
47
2
AAPL
40
-6
RSG
65
-3
Financhill
Back

SPDR® SSgA Global Allocation ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
48

GAL
SPDR® SSgA Global Allocation ETF

Last Price:
44.78
Seasonality Move:
1.74%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.87
Seasonality Move:
17.03%
Sell
48
SPDR® SSgA Global Allocation ETF (GAL) is a Sell

Is SPDR® SSgA Global Allocation ETF a Buy, Sell or Hold?

  • The current SPDR® SSgA Global Allocation ETF [GAL] share price is $44.78. The Score for GAL is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • GAL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GAL Stock Price Chart

What is SPDR® SSgA Global Allocation ETF's stock price today?

  • The SPDR® SSgA Global Allocation ETF share price today is $44.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GAL is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GAL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 42.61 Sell
Chaikin Money Flow: -648 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.84 - 45.44) Sell
Bollinger Bands (100): (43.7 - 45.3) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GAL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.27 Sell
20-day SMA: 45.07 Sell
50-day SMA: 45.13 Sell
200-day SMA: 43.64 Buy
8-day EMA: 45.1 Sell
20-day EMA: 45.13 Sell
50-day EMA: 44.98 Sell
200-day EMA: 43.61 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

SPDR® SSgA Global Allocation ETF Earnings Growth & GAL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

SPDR® SSgA Global Allocation ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):